series-b
Stage
2
Investors
About
Refined Diagnostics is a Münster, Germany–based medical technology company that develops laser-based, stain-free molecular tissue imaging systems (including Raman imaging) for real-time intraoperative and pathology analysis. Their systems aim to provide rapid, molecular-level insight into tissue architecture to assist surgeons and pathologists with tumor margin assessment.
Explore Refined Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.